Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-16-014055
Filing Date
2016-04-05
Accepted
2016-04-05 16:55:35
Documents
2
Period of Report
2016-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_145988972387473.html 4  
1 FORM 4 wf-form4_145988972387473.xml 4 3705
2 GILMAN POA gilmanpoa.htm EX-24 3684
  Complete submission text file 0001628280-16-014055.txt   8718
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
GILMAN STEVEN C (Reporting) CIK: 0001379970 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 161555197